Laboratoire Innotech International   Report issue

For profit Phase 3 Phase 4
Founded: Arcueil France (1913)
Status: No NME R&D (1913)

Organization Overview

First Clinical Trial
2009
NCT02444481
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Laboratoire Innotech International

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia (Phase 4)

Anemia, Iron-Deficiency (Phase 4)

Vaginitis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 7